| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | KD8QND6427 |
Structure
| InChI Key | KJXSIXMJHKAJOD-LSDHHAIUSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C15H12O8 |
| Molecular Weight | 320.25 |
| AlogP | 0.89 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 6.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 147.68 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 23.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
|
- | 12800 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 28429 |
| ChEMBL | CHEMBL3348861 |
| DrugBank | DB15645 |
| EPA CompTox | DTXSID50181676 |
| FDA SRS | KD8QND6427 |
| KEGG | C02906 |
| SureChEMBL | SCHEMBL723736 |
| ZINC | ZINC000100037633 |
CONTENTS